Position in OCS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,614,834
+$582,348 QoQ
Shares Held
98,339
-3.4% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
2.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACUTA CAPITAL PARTNERS, LLC holds $139,270,289 across 21 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
82,796 | $27,719,272 | |
| 2 | WHWK |
Whitehawk Therapeutics, Inc.
|
4,685,912 | $21,461,476 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
390,949 | $12,221,065 | |
| 4 | STRO |
Sutro Biopharma, Inc.
|
270,251 | $8,972,333 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
218,694 | $7,597,429 | |
| 6 | FDMT |
4D Molecular Therapeutics, Inc.
|
507,801 | $6,753,753 | |
| 7 | DRUG |
Bright Minds Biosciences Inc.
|
92,745 | $6,510,699 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
532,481 | $5,228,963 |
All Filings in OCS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,614,834 | 98,339 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,032,486 | 101,777 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,789,239 | 101,777 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,071,396 | 106,718 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,378,750 | 125,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||